GNCA
Genocea Biosciences, Inc.
No insider bought or sold Genocea Biosciences, Inc. in the last 12 months
$0Bought, 12 mo
$0Sold, 12 mo
GNCA over the last year
Prices for GNCA aren't in yet.
GNCA after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
13 insider filings since 2017, newest first
GNCASell
New Enterprise Associates 16, L.P. · 10% owner
$751K−100.0%May 26
GNCASell
Ali Behbahani · Director and 10% owner
$751K−100.0%May 26
GNCASell
Paul Edward Walker · 10% owner
$751K−100.0%May 26
GNCASell
Peter W. Sonsini · 10% owner
$751K−100.0%May 26
GNCASell
Scott D Sandell · 10% owner
$751K−100.0%May 26
GNCASell
Mohamad Makhzoumi · 10% owner
$751K−100.0%May 26
GNCASell
Anthony A. Florence Jr. · 10% owner
$751K−100.0%May 26
GNCASell
Carmen Chang · 10% owner
$751K−100.0%May 26
GNCASell
Forest Baskett · 10% owner
$751K−100.0%May 26
GNCABuy
George Siber · Director
$100KSep 24
GNCASell
Jonathan Poole · CFO
$270K−53.0%Jul 24
GNCABuy
George Siber · Director
$322K−104.0%May 22
GNCASell
Jonathan Poole · CFO
$40K−14.0%May 10
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.